id,filing_uuid,filing_type,registrant_name,registrant_id,client_name,filing_year,filing_period,issue_code,specific_issues,government_entities,income_amount,expense_amount,is_no_activity,is_termination,received_date
2433402,718772aa-eecf-4d8c-88bf-cd2fa3f455aa,Q1,"WILLIAMS AND JENSEN, PLLC",41454,MERCK & CO INC,2020,first_quarter,BUD,"Policies impacting Medicare Part D.  Drug Development and Public Health Preparedness.  Policies impacting U.S. address to the Covid-19 pandemic, including H.R. 604 Coronavirus Preparedness and Response Supplemental Appropriations Act, Public Law No: 116-123.; H. R . 6201  Families First Coronavirus Response Act, Public Law No: 116-127; and H. R. 748  CARES Act, Public Law No: 116-136.","Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE,White House Office",80000,,0,0,2020-04-17T16:20:51.220000-04:00